Cough and Sinus Congestion Treatment in Elderly Patients

Initial Assessment and Classification

A subacute cough (3-8 weeks duration) with upper airway symptoms, likely representing postinfectious cough and/or upper airway cough syndrome (UACS), is a common presentation in elderly patients with a 3-week cough and sinus congestion 3, 4
Multiple pathogenetic factors, including postviral airway inflammation, mucus hypersecretion, impaired mucociliary clearance, and UACS, may contribute to this presentation 3
A cough lasting 3 weeks falls into the "postinfectious cough" category, which typically lasts 3-8 weeks following an acute respiratory infection 4, 5

The American College of Chest Physicians recommends a first-generation antihistamine/decongestant combination as the first-line treatment for UACS-induced cough and sinus congestion in elderly patients 1, 2, 6
Starting with a once-daily bedtime dose for a few days before increasing to twice-daily therapy can help minimize sedation effects, particularly important in elderly patients 2, 6
Intranasal corticosteroids should be added to decrease inflammation, especially if nasal congestion is prominent, as recommended by the American College of Chest Physicians 1, 2

The American Geriatrics Society recommends monitoring carefully for side effects of first-generation antihistamines and decongestants in elderly patients, including urinary retention, increased intraocular pressure, sedation, insomnia, jitteriness, tachycardia, and worsening hypertension 1, 2, 6
Inhaled ipratropium bromide may be considered as an alternative or additional therapy to attenuate cough with fewer systemic side effects, as suggested by the American College of Chest Physicians 3, 5

The American College of Chest Physicians recommends considering inhaled corticosteroids if cough persists despite first-line therapy and adversely affects quality of life 3, 4
Central-acting antitussive agents (codeine or dextromethorphan) may be considered when other measures fail, as recommended by the American College of Chest Physicians 3, 7
Short-term prednisone (30-40 mg daily) may be considered for severe paroxysms of cough after ruling out other common causes, as suggested by the American College of Chest Physicians 3

The American Academy of Otolaryngology recommends avoiding nasal decongestant sprays for more than 3-5 days due to the risk of rebound congestion (rhinitis medicamentosa) 2, 6
Monitoring for drug interactions is crucial, especially with any existing medications elderly patients may be taking, as recommended by the American Geriatrics Society 5
If symptoms worsen or fail to improve within 7-10 days of treatment, reevaluation for other causes or complications is necessary, as suggested by the American College of Chest Physicians 1, 7